SIMILAR PATTERNS OF AMINO ACIDS FOR 6CJK_B_ACTB302_0
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ad0 | ANTIBODY A5B7 (HEAVYCHAIN) (Homo sapiens) |
PF07654(C1-set)PF07686(V-set) | 3 | TYR B 59GLY B 65THR B 68 | None | 0.19A | 6cjkB-1ad0B:26.4 | 6cjkB-1ad0B:61.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1axt | IMMUNOGLOBULIN IGG2A (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 3 | TYR H 59GLY H 65THR H 68 | None | 0.15A | 6cjkB-1axtH:24.8 | 6cjkB-1axtH:58.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1f4w | ANTIBODY S-20-4, FABFRAGMENT, HEAVYCHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 3 | TYR H 60GLY H 66THR H 69 | None | 0.19A | 6cjkB-1f4wH:23.0 | 6cjkB-1f4wH:56.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1h0d | ANTIBODY FABFRAGMENT, HEAVYCHAIN (Homo sapiens) |
PF07654(C1-set)PF07686(V-set) | 3 | TYR B 59GLY B 65THR B 68 | None | 0.10A | 6cjkB-1h0dB:24.9 | 6cjkB-1h0dB:58.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1i9i | RECOMBINANTMONOCLONALANTI-TESTOSTERONEFAB FRAGMENT HEAVYCHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 3 | TYR H 59GLY H 65THR H 68 | None | 0.15A | 6cjkB-1i9iH:25.9 | 6cjkB-1i9iH:57.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1igj | IGG2A-KAPPA 26-10FAB (HEAVY CHAIN) (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 3 | TYR B 59GLY B 65THR B 68 | None | 0.16A | 6cjkB-1igjB:15.7 | 6cjkB-1igjB:54.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ohq | IMMUNOGLOBULIN (Homo sapiens) |
PF07686(V-set) | 3 | TYR A 60GLY A 66THR A 69 | None | 0.17A | 6cjkB-1ohqA:18.4 | 6cjkB-1ohqA:58.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1q5a | EP-CADHERIN (Mus musculus) |
PF00028(Cadherin) | 3 | TYR A 471GLY A 437THR A 468 | None CA A 914 ( 4.0A)None | 0.00A | 6cjkB-1q5aA:undetectable | 6cjkB-1q5aA:13.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1rjc | CAMELID HEAVY CHAINANTIBODY (Camelusdromedarius) |
PF07686(V-set) | 3 | TYR A 60GLY A 66THR A 69 | None | 0.17A | 6cjkB-1rjcA:18.0 | 6cjkB-1rjcA:29.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1s3k | HU3S193 FABFRAGMENT, HEAVYCHAIN (Homo sapiens;Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 3 | TYR H 60GLY H 66THR H 69 | None | 0.19A | 6cjkB-1s3kH:25.2 | 6cjkB-1s3kH:61.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1shm | ANTIBODY RIG (Lama glama) |
PF07686(V-set) | 3 | TYR A 59GLY A 65THR A 68 | None | 0.08A | 6cjkB-1shmA:20.3 | 6cjkB-1shmA:35.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1sjx | IMMUNOGLOBULIN VHDOMAIN (Lama glama) |
PF07686(V-set) | 3 | TYR A 859GLY A 865THR A 868 | None | 0.19A | 6cjkB-1sjxA:19.9 | 6cjkB-1sjxA:28.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1t66 | IMMUNOGLOBULIN HEAVYCHAIN (Mus musculus) |
no annotation | 3 | TYR H 62GLY H 68THR H 71 | None | 0.19A | 6cjkB-1t66H:24.7 | 6cjkB-1t66H:58.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1wz1 | IG HEAVY CHAIN (Mus musculus) |
PF07686(V-set) | 3 | TYR H 62GLY H 68THR H 71 | None | 0.19A | 6cjkB-1wz1H:20.0 | 6cjkB-1wz1H:43.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1x9q | 4M5.3ANTI-FLUORESCEINSINGLE CHAINANTIBODY FRAGMENT (Homo sapiens) |
PF07686(V-set) | 3 | TYR A 213GLY A 219THR A 222 | None | 0.11A | 6cjkB-1x9qA:19.3 | 6cjkB-1x9qA:25.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1xfp | HEAVY CHAIN ANTIBODY (Camelusdromedarius) |
PF07686(V-set) | 3 | TYR A 60GLY A 66THR A 69 | None | 0.10A | 6cjkB-1xfpA:18.0 | 6cjkB-1xfpA:31.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1zvy | IMMUNOGLOBULIN HEAVYCHAIN ANTIBODYVARIABLE DOMAIN (Camelusdromedarius) |
PF07686(V-set) | 3 | TYR A 60GLY A 66THR A 69 | None | 0.17A | 6cjkB-1zvyA:19.6 | 6cjkB-1zvyA:32.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2a77 | IMMUNOGLOBULIN HEAVYCHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 3 | TYR H 60GLY H 66THR H 69 | None | 0.18A | 6cjkB-2a77H:24.6 | 6cjkB-2a77H:56.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2b2x | ANTIBODY AQC2 FAB (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 3 | TYR H 59GLY H 65THR H 68 | None | 0.14A | 6cjkB-2b2xH:25.7 | 6cjkB-2b2xH:62.61 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2uud | NQ10-1.12 ANTI-PHOXANTIBODY (Mus musculus) |
PF07686(V-set) | 3 | TYR H 59GLY H 65THR H 68 | None | 0.18A | 6cjkB-2uudH:20.1 | 6cjkB-2uudH:57.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xxm | CAMELID VHH 9 (Vicugna pacos) |
PF07686(V-set) | 3 | TYR B 59GLY B 65THR B 68 | None | 0.16A | 6cjkB-2xxmB:17.5 | 6cjkB-2xxmB:28.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ypv | FAB 12C1 (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 3 | TYR H 60GLY H 66THR H 69 | None | 0.19A | 6cjkB-2ypvH:22.7 | 6cjkB-2ypvH:52.23 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3b9v | HEAVY CHAIN VARIABLEDOMAIN (Homo sapiens) |
PF07686(V-set) | 3 | TYR A 59GLY A 65THR A 68 | None | 0.09A | 6cjkB-3b9vA:20.0 | 6cjkB-3b9vA:61.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3c2a | FAB 447-52D HEAVYCHAIN (Homo sapiens) |
PF07654(C1-set)PF07686(V-set) | 3 | TYR H 59GLY H 65THR H 68 | None | 0.19A | 6cjkB-3c2aH:20.6 | 6cjkB-3c2aH:59.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3fzu | IMMUNOGLOBULIN IGG1FAB, HEAVY CHAIN (Homo sapiens) |
no annotation | 3 | TYR H 62GLY H 68THR H 71 | None | 0.16A | 6cjkB-3fzuH:25.0 | 6cjkB-3fzuH:59.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3g9a | MINIMIZER (Camelusdromedarius) |
PF07686(V-set) | 3 | TYR B 59GLY B 65THR B 68 | None | 0.18A | 6cjkB-3g9aB:18.0 | 6cjkB-3g9aB:34.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ghe | FAB 537-10D, HEAVYCHAIN (Homo sapiens) |
PF07654(C1-set)PF07686(V-set) | 3 | TYR H 59GLY H 65THR H 68 | None | 0.17A | 6cjkB-3gheH:19.9 | 6cjkB-3gheH:58.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3i9g | SONEPCIZUMABANTIBODY FABFRAGMENT, HEAVYCHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 3 | TYR H 59GLY H 65THR H 68 | None | 0.16A | 6cjkB-3i9gH:23.8 | 6cjkB-3i9gH:54.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ntc | FAB HEAVY CHAIN (Homo sapiens;Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 3 | TYR H 59GLY H 65THR H 68 | None | 0.19A | 6cjkB-3ntcH:24.2 | 6cjkB-3ntcH:53.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3nzh | 5F6 HEAVY CHAIN (Homo sapiens;Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 3 | TYR H 63GLY H 69THR H 72 | None | 0.15A | 6cjkB-3nzhH:23.7 | 6cjkB-3nzhH:60.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3p9w | HUMAN VEGF (Homo sapiens) |
PF07686(V-set) | 3 | TYR B 59GLY B 65THR B 68 | TYR B 59 ( 1.3A)GLY B 65 ( 0.0A)THR B 68 ( 0.8A) | 0.12A | 6cjkB-3p9wB:18.7 | 6cjkB-3p9wB:37.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3qyc | VH DOMAIN OF IGGMOLECULE (Homo sapiens) |
PF07686(V-set) | 3 | TYR A 62GLY A 68THR A 71 | None | 0.19A | 6cjkB-3qycA:19.1 | 6cjkB-3qycA:34.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3tpk | IMMUNOGLOBULIN HEAVYCHAIN ANTIBODYVARIABLE DOMAIN KW1 (Camelidae) |
PF07686(V-set) | 3 | TYR A 60GLY A 66THR A 69 | None | 0.14A | 6cjkB-3tpkA:19.3 | 6cjkB-3tpkA:34.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3zhk | MG2X1 SCAFFOLDANTIBODY (Homo sapiens) |
PF07686(V-set) | 3 | TYR A 60GLY A 66THR A 69 | None | 0.12A | 6cjkB-3zhkA:20.5 | 6cjkB-3zhkA:36.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3zks | XA4813 (Lama glama) |
PF07686(V-set) | 3 | TYR D 219GLY D 225THR D 228 | None | 0.18A | 6cjkB-3zksD:19.4 | 6cjkB-3zksD:32.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4b41 | ANTIBODY G7 (Lama glama) |
PF07686(V-set) | 3 | TYR A 59GLY A 65THR A 68 | None | 0.13A | 6cjkB-4b41A:19.0 | 6cjkB-4b41A:35.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4b50 | 2H10 LLAMA VHH (Lama glama) |
PF07686(V-set) | 3 | TYR A 59GLY A 65THR A 68 | None | 0.17A | 6cjkB-4b50A:19.5 | 6cjkB-4b50A:38.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4c57 | NANOBODY (Lama glama) |
PF07686(V-set) | 3 | TYR C 67GLY C 74THR C 77 | None | 0.18A | 6cjkB-4c57C:17.0 | 6cjkB-4c57C:35.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4dgy | HCV1 HEAVY CHAIN (Homo sapiens) |
PF07654(C1-set)PF07686(V-set) | 3 | TYR H 59GLY H 65THR H 68 | None | 0.16A | 6cjkB-4dgyH:23.5 | 6cjkB-4dgyH:60.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4dka | SINGLE DOMAINANTIBODY VHH (Lama glama) |
PF07686(V-set) | 3 | TYR A 60GLY A 66THR A 69 | None | 0.11A | 6cjkB-4dkaA:18.3 | 6cjkB-4dkaA:35.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ej1 | NB113 CAMELIDANTIBODY FRAGMENT (Lama glama) |
PF07686(V-set) | 3 | TYR C 60GLY C 66THR C 69 | None | 0.14A | 6cjkB-4ej1C:19.5 | 6cjkB-4ej1C:34.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4f58 | HEAVY CHAIN OF FABOF A NEUTRALIZINGANTIBODY L3 (Homo sapiens) |
PF07654(C1-set)PF07686(V-set) | 3 | TYR H 59GLY H 65THR H 68 | SO4 H 301 (-4.2A)NoneSO4 H 301 ( 4.3A) | 0.14A | 6cjkB-4f58H:19.9 | 6cjkB-4f58H:61.23 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4fql | MONOCLONAL ANTIBODYCR8033 HEAVY CHAIN (Homo sapiens) |
PF07654(C1-set)PF07686(V-set) | 3 | TYR H 59GLY H 65THR H 68 | None | 0.17A | 6cjkB-4fqlH:24.7 | 6cjkB-4fqlH:60.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4grw | NANOBODY 37D5 (Lama glama) |
PF07686(V-set) | 3 | TYR F 60GLY F 66THR F 69 | None | 0.16A | 6cjkB-4grwF:17.4 | 6cjkB-4grwF:51.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4hdi | IG HEAVY CHAIN VREGION RF, IGGAMMA-3 CHAIN CREGION (Mus musculus) |
no annotation | 3 | TYR H 60GLY H 66THR H 69 | None | 0.16A | 6cjkB-4hdiH:24.6 | 6cjkB-4hdiH:56.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4hem | ANTI-BASEPLATETP901-1 LLAMA VHH 02 (Lama glama) |
PF07686(V-set) | 3 | TYR E 60GLY E 66THR E 69 | None | 0.14A | 6cjkB-4hemE:18.6 | 6cjkB-4hemE:34.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4i0c | CABHUL5 ANTIBODY (Camelusdromedarius) |
PF07686(V-set) | 3 | TYR C 58GLY C 64THR C 67 | None | 0.12A | 6cjkB-4i0cC:19.1 | 6cjkB-4i0cC:29.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4jo3 | MONOCLONALANTI-HIV-1 GP120 V3ANTIBODY R20 HEAVYCHAIN (Oryctolaguscuniculus) |
PF07654(C1-set)PF07686(V-set) | 3 | TYR H 59GLY H 65THR H 68 | None | 0.10A | 6cjkB-4jo3H:27.7 | 6cjkB-4jo3H:84.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4kfz | ANTI-LMO2 VH (Homo sapiens) |
PF07686(V-set) | 3 | TYR C 60GLY C 66THR C 69 | None | 0.12A | 6cjkB-4kfzC:18.5 | 6cjkB-4kfzC:60.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4kml | NANOBODY (Lama glama) |
PF07686(V-set) | 3 | TYR B 60GLY B 66THR B 69 | None | 0.15A | 6cjkB-4kmlB:19.3 | 6cjkB-4kmlB:31.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4krm | NANOBODY/VHH DOMAIN7D12 (Lama glama) |
PF07686(V-set) | 3 | TYR B 60GLY B 66THR B 69 | None | 0.17A | 6cjkB-4krmB:19.5 | 6cjkB-4krmB:31.03 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4krn | NANOBODY/VHH DOMAINEGA1 (Lama glama) |
PF07686(V-set) | 3 | TYR A 60GLY A 66THR A 69 | None | 0.19A | 6cjkB-4krnA:19.2 | 6cjkB-4krnA:34.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4kvc | IG HEAVY CHAIN VREGION MOPC 21, IGHPROTEIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 3 | TYR H 60GLY H 66THR H 69 | None | 0.15A | 6cjkB-4kvcH:25.0 | 6cjkB-4kvcH:61.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4lgr | CAMELID NANOBODY(VHH3) (Vicugna pacos) |
PF07686(V-set) | 3 | TYR B 59GLY B 65THR B 68 | None | 0.14A | 6cjkB-4lgrB:19.1 | 6cjkB-4lgrB:29.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4lrn | GEP 1 HEAVY CHAIN (Homo sapiens) |
PF07686(V-set) | 3 | TYR H 59GLY H 65THR H 68 | None | 0.16A | 6cjkB-4lrnH:18.2 | 6cjkB-4lrnH:31.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4m3k | CAMELID HEAVY-CHAINANTIBODY VARIABLEFRAGMENT CAB-H7S (Lama glama) |
PF07686(V-set) | 3 | TYR B 59GLY B 65THR B 68 | None | 0.17A | 6cjkB-4m3kB:16.8 | 6cjkB-4m3kB:31.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mqt | NANOBODY 9-8 (Lama glama) |
PF07686(V-set) | 3 | TYR B 63GLY B 69THR B 72 | None | 0.12A | 6cjkB-4mqtB:19.2 | 6cjkB-4mqtB:48.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4nbz | A26.8 VHH (Lama glama) |
PF07686(V-set) | 3 | TYR B 60GLY B 66THR B 69 | None | 0.19A | 6cjkB-4nbzB:18.5 | 6cjkB-4nbzB:32.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4nc1 | A26.8 VHH (Lama glama) |
PF07686(V-set) | 3 | TYR E 60GLY E 66THR E 69 | None | 0.15A | 6cjkB-4nc1E:19.1 | 6cjkB-4nc1E:29.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4o5l | FAB F045-092 HEAVYCHAIN (Homo sapiens) |
PF07654(C1-set)PF07686(V-set) | 3 | TYR H 59GLY H 65THR H 68 | None | 0.19A | 6cjkB-4o5lH:23.6 | 6cjkB-4o5lH:53.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ocl | NB1 (Lama glama) |
PF07686(V-set) | 3 | TYR C 61GLY C 67THR C 70 | None | 0.11A | 6cjkB-4oclC:19.3 | 6cjkB-4oclC:29.87 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ocr | CAP256-VRC26.01HEAVY CHAIN (Homo sapiens) |
PF07654(C1-set)PF07686(V-set) | 3 | TYR H 59GLY H 65THR H 68 | None | 0.19A | 6cjkB-4ocrH:19.3 | 6cjkB-4ocrH:53.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4pb0 | AB53 HEAVY CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 3 | TYR H 59GLY H 65THR H 68 | NoneNone CL H 305 ( 4.6A) | 0.15A | 6cjkB-4pb0H:24.6 | 6cjkB-4pb0H:60.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4r90 | ANTI CD70 LLAMAGLAMA FAB 27B3 HEAVYCHAIN (Lama glama) |
PF07654(C1-set)PF07686(V-set) | 3 | TYR H 60GLY H 66THR H 69 | None | 0.11A | 6cjkB-4r90H:19.4 | 6cjkB-4r90H:60.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4r96 | LLAMA GLAMA FAB 48A2AGAINST HUMAN CMET HCHAIN (Lama glama) |
PF07654(C1-set)PF07686(V-set) | 3 | TYR B 60GLY B 66THR B 69 | None | 0.19A | 6cjkB-4r96B:24.1 | 6cjkB-4r96B:53.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4rav | SINGLE-CHAIN FV, VH (Homo sapiens) |
PF07686(V-set) | 3 | TYR A 60GLY A 66THR A 69 | None | 0.16A | 6cjkB-4ravA:20.2 | 6cjkB-4ravA:46.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4rgn | 14G8 HEAVY CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 3 | TYR B 59GLY B 65THR B 68 | None | 0.12A | 6cjkB-4rgnB:25.2 | 6cjkB-4rgnB:56.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4tvs | VHH DOMAIN BS-1 (Vicugna pacos) |
PF05609(LAP1C) | 3 | TYR a 61GLY a 67THR a 70 | None | 0.15A | 6cjkB-4tvsa:19.1 | 6cjkB-4tvsa:32.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4u6v | FAB, ANTIGEN BINDINGFRAGMENT, HEAVYCHAIN (Homo sapiens) |
PF07654(C1-set)PF07686(V-set) | 3 | TYR H 59GLY H 65THR H 68 | SO4 H 301 (-4.3A)NoneNone | 0.14A | 6cjkB-4u6vH:24.0 | 6cjkB-4u6vH:60.87 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4uom | FAB FRAGMENT HEAVYCHAIN (Homo sapiens) |
PF07654(C1-set)PF07686(V-set) | 3 | TYR H 60GLY H 66THR H 69 | None | 0.16A | 6cjkB-4uomH:25.2 | 6cjkB-4uomH:54.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4uu9 | MEDI7814 (Homo sapiens) |
PF07686(V-set) | 3 | TYR A 59GLY A 65THR A 68 | None | 0.14A | 6cjkB-4uu9A:20.5 | 6cjkB-4uu9A:58.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4w6x | NANOBODY NBFEDF7 (Lama glama) |
PF07686(V-set) | 3 | TYR B 59GLY B 66THR B 69 | None | 0.12A | 6cjkB-4w6xB:19.0 | 6cjkB-4w6xB:34.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4w6y | NANOBODY NBFEDF9 (Lama glama) |
PF07686(V-set) | 3 | TYR B 60GLY B 66THR B 69 | None | 0.19A | 6cjkB-4w6yB:19.9 | 6cjkB-4w6yB:33.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4weu | ANTI-F4+ETECBACTERIA VHHVARIABLE REGION (Lama glama) |
PF07686(V-set) | 3 | TYR D 860GLY D 866THR D 869 | None | 0.12A | 6cjkB-4weuD:20.0 | 6cjkB-4weuD:31.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4wht | HEAVY CHAIN OF THEFAB FRAGMENT DERIVEDFROM NEUTRALIZINGANTIBODY 3/11 (Rattusnorvegicus) |
PF07654(C1-set)PF07686(V-set) | 3 | TYR A 60GLY A 66THR A 69 | None | 0.19A | 6cjkB-4whtA:23.5 | 6cjkB-4whtA:52.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4xvj | ANTIBODY HEAVY CHAINVARIABLE DOMAIN (Homo sapiens) |
PF07686(V-set) | 3 | TYR H 60GLY H 66THR H 69 | None | 0.18A | 6cjkB-4xvjH:19.9 | 6cjkB-4xvjH:41.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4y5v | DIABODY 305 VHDOMAIN (Homo sapiens) |
PF07686(V-set) | 3 | TYR A 60GLY A 66THR A 69 | None | 0.12A | 6cjkB-4y5vA:20.3 | 6cjkB-4y5vA:43.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4y8d | NANOBODY (Lama glama) |
PF07686(V-set) | 3 | TYR C 57GLY C 63THR C 66 | NoneEDO C 202 (-4.3A)EDO C 202 (-4.0A) | 0.16A | 6cjkB-4y8dC:17.8 | 6cjkB-4y8dC:32.74 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ybq | ANTIBODY FV FRAGMENTHEAVY CHAIN (Mus musculus) |
PF07686(V-set) | 3 | TYR D 61GLY D 67THR D 70 | None | 0.19A | 6cjkB-4ybqD:20.5 | 6cjkB-4ybqD:42.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4yhp | FAB HEAVY CHAIN (Homo sapiens) |
PF07654(C1-set)PF07686(V-set) | 3 | TYR A 60GLY A 66THR A 69 | None | 0.16A | 6cjkB-4yhpA:25.5 | 6cjkB-4yhpA:61.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4z9k | VHH2(F5) ANTIBODY (Vicugna pacos) |
PF07686(V-set) | 3 | TYR B 58GLY B 64THR B 67 | None | 0.19A | 6cjkB-4z9kB:16.3 | 6cjkB-4z9kB:31.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4zpt | D12 FAB HEAVY CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 3 | TYR A 59GLY A 65THR A 68 | None | 0.14A | 6cjkB-4zptA:26.0 | 6cjkB-4zptA:61.99 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5b3n | ANTI-H4K20ME1_SCFV (Mus musculus) |
PF07686(V-set) | 3 | TYR A 62GLY A 68THR A 71 | None | 0.20A | 6cjkB-5b3nA:19.9 | 6cjkB-5b3nA:37.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5b6f | ANTI-LEUKOTRIENE C4MONOCLONAL ANTIBODYIMMUNOGLOBULINGAMMA1 HEAVY CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 3 | TYR B 81GLY B 87THR B 90 | None | 0.14A | 6cjkB-5b6fB:25.2 | 6cjkB-5b6fB:31.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5c2b | SCFV 3B4 HEAVY CHAIN (Homo sapiens) |
PF07686(V-set) | 3 | TYR H 60GLY H 66THR H 69 | None | 0.15A | 6cjkB-5c2bH:19.6 | 6cjkB-5c2bH:36.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5c6w | PROTEINIGHV1-69-2,IG LAMBDACHAIN V-II REGIONNIG-84 (Homo sapiens) |
PF07686(V-set) | 3 | TYR H 60GLY H 66THR H 69 | None | 0.17A | 6cjkB-5c6wH:18.8 | 6cjkB-5c6wH:33.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5d1z | Y10 HEAVY CHAIN (Homo sapiens) |
PF07654(C1-set)PF07686(V-set) | 3 | TYR B 61GLY B 67THR B 70 | None | 0.18A | 6cjkB-5d1zB:22.9 | 6cjkB-5d1zB:60.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5d9q | NIH45-46 SINGLECHAIN FV (Homo sapiens) |
PF07686(V-set) | 3 | TYR D 59GLY D 65THR D 68 | None | 0.00A | 6cjkB-5d9qD:undetectable | 6cjkB-5d9qD:30.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5dlm | HEAVY CHAIN OFMONOCLONAL ANTIBODY (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 3 | TYR H 59GLY H 65THR H 68 | None | 0.15A | 6cjkB-5dlmH:25.2 | 6cjkB-5dlmH:58.37 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5do2 | 4C2 HEAVY CHAIN (Mus musculus) |
no annotation | 3 | TYR H 60GLY H 66THR H 69 | None | 0.13A | 6cjkB-5do2H:25.5 | 6cjkB-5do2H:58.74 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5dr5 | ABD09097 FAB HEAVYCHAIN (Homo sapiens) |
PF07654(C1-set)PF07686(V-set) | 3 | TYR H 60GLY H 66THR H 69 | None | 0.16A | 6cjkB-5dr5H:24.3 | 6cjkB-5dr5H:58.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5dxw | PD-L1 NANOBODY (Mus musculus) |
PF07686(V-set) | 3 | TYR A 62GLY A 68THR A 71 | None | 0.17A | 6cjkB-5dxwA:19.2 | 6cjkB-5dxwA:32.61 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5f1k | NANOBODY MU1053 (Lama glama) |
PF07686(V-set) | 3 | TYR C 60GLY C 66THR C 69 | None | 0.14A | 6cjkB-5f1kC:20.4 | 6cjkB-5f1kC:33.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5f1o | NANOBODY MU551 (Lama glama) |
PF07686(V-set) | 3 | TYR B 60GLY B 66THR B 69 | None | 0.17A | 6cjkB-5f1oB:19.4 | 6cjkB-5f1oB:32.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5gs1 | DIABODY (Homo sapiens) |
PF07686(V-set) | 3 | TYR C 59GLY C 65THR C 68 | None | 0.18A | 6cjkB-5gs1C:19.6 | 6cjkB-5gs1C:42.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5hgg | CAMELID DERIVEDANTIBODY FRAGMENT,NB4 (Vicugna pacos) |
PF07686(V-set) | 3 | TYR S 60GLY S 66THR S 69 | None | 0.17A | 6cjkB-5hggS:18.7 | 6cjkB-5hggS:35.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5hm1 | LAMA VHH ANTIBODY2E7 (Lama glama) |
PF07686(V-set) | 3 | TYR A 59GLY A 65THR A 68 | None | 0.18A | 6cjkB-5hm1A:17.4 | 6cjkB-5hm1A:52.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5j1s | VHH DOMAIN BS-2 (Vicugna pacos) |
PF07686(V-set) | 3 | TYR C 60GLY C 66THR C 69 | None | 0.16A | 6cjkB-5j1sC:19.3 | 6cjkB-5j1sC:51.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5j56 | VHH SINGLE CHAINANTIBODY V1C7 (Vicugna pacos) |
PF07686(V-set) | 3 | TYR B 64GLY B 70THR B 73 | None | 0.16A | 6cjkB-5j56B:18.1 | 6cjkB-5j56B:53.03 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ja9 | NANOBODY 6 (Lama glama) |
PF07686(V-set) | 3 | TYR A 61GLY A 67THR A 70 | None | 0.20A | 6cjkB-5ja9A:19.2 | 6cjkB-5ja9A:30.97 |